The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.
With Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug
Related Posts
Popular News
-
Sam Altman World Foundation Crypto Offloads 239M WLD Tokens for $65M Near All-Time Lows
-
Will Bitcoin price rally as Trump pushes for ceasefire in ongoing U.S.–Iran war?
-
Analyst Reveals Bitcoin Strategy With 250% Potential Upside — Key Entry Levels Identified
-
Ex-PFS board member lays out ‘grave concerns’ over CII finances
-
Solana DEX PnP Integrates DeFiLlama for On-Chain Prediction Markets
Latest News
Circle mints $750M USDC on Solana as stablecoin flows pivot back on‑chain
Circle minted about $750M USDC on Solana in 24 hours, adding major dollar liquidity as the chain’s DeFi, trading and...
Warren Buffett says he’s still making investment calls at Berkshire, flags ‘tiny’ buy
Warren Buffett said Tuesday he remains closely involved in investment decisions at Berkshire Hathaway even after stepping down as chief...
Senior Coordinator of Business Career Services
Senior Coordinator of Business Career ServicesPosition Title & Department:Senior Coordinator of Business Career Services; School of Business...
Breakwall and Vitol close second mining credit fund
Asset management firm Breakwall Capital and energy and commodities company Vitol have closed their second private credit fund focused on...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.